Automated Detection and Segmentation of Brain Metastases in Malignant Melanoma: Evaluation of a Dedicated Deep Learning Model

References

1. 1.↵
   1. Davies MA,
   2. Liu P,
   3. McIntyre S, et al

   . Prognostic factors for survival in patients with melanoma with brain metastases. Cancer 2011;117:1687–96 doi:10.1002/cncr.25634 pmid:20960525

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Jakob JA,
   2. Bassett RL,
   3. Ng CS, et al

   . NRAS mutation status is an independent prognostic factor in metastatic melanoma. Cancer 2012;118:4014–23 doi:10.1002/cncr.26724 pmid:22180178

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Goyal S,
   2. Silk AW,
   3. Tian S, et al

   . Clinical management of multiple melanoma brain metastases a systematic review. JAMA Oncol 2015;1:668–76 doi:10.1001/jamaoncol.2015.1206 pmid:26181286

   CrossRefPubMed
4. 4.↵
   1. Sperduto PW,
   2. Kased N,
   3. Roberge D, et al

   . Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 2012;30:419–25 doi:10.1200/JCO.2011.38.0527 pmid:22203767

   Abstract/FREE Full Text
5. 5.↵
   1. Michielin O,
   2. van Akkooi A,
   3. Ascierto P, et al

   ; ESMO Guidelines Committee. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2019;30:1884–1901 doi:10.1093/annonc/mdz411 pmid:31566661

   CrossRefPubMed
6. 6.↵
   1. Schlamann M,
   2. Loquai C,
   3. Goericke S, et al

   . Cerebral MRI in neurological asymptomatic patients with malignant melanoma [in German]. Rofo 2008;180:143–47 doi:10.1055/s-2007-963711 pmid:18098094

   CrossRefPubMed
7. 7.↵
   1. Garbe C,
   2. Amaral T,
   3. Peris K, et al

   . European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2019. Eur J Cancer 2020;126:141–158 doi:10.1016/j.ejca.2019.11.014 pmid:31928887

   CrossRefPubMed
8. 8.↵
   1. Trotter SC,
   2. Sroa N,
   3. Winkelmann RR, et al

   . A global review of melanoma follow-up guidelines. J Clin Aesthet Dermatol 2013;6(9):18–26 pmid:24062870

   PubMed
9. 9.↵
   1. Berbaum KS,
   2. Franken EA,
   3. Dorfman DD, et al

   . Satisfaction of search in diagnostic radiology. Invest Radiol 1990;25:133–40 doi:10.1097/00004424-199002000-00006 pmid:2312249

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Brady AP

    . Error and discrepancy in radiology: inevitable or avoidable? Insights Imaging 2017;8:171–82 doi:10.1007/s13244-016-0534-1 pmid:27928712

    CrossRefPubMed
11. 11.↵
    1. Conson M,
    2. Cella L,
    3. Pacelli R, et al

    . Automated delineation of brain structures in patients undergoing radiotherapy for primary brain tumors: from atlas to dose-volume histograms. Radiother Oncol 2014;112:326–31 doi:10.1016/j.radonc.2014.06.006 pmid:25012642

    CrossRefPubMed
12. 12.↵
    1. Xue Y,
    2. Chen S,
    3. Qin J, et al

    . Application of deep learning in automated analysis of molecular images in cancer: a survey. Contrast Media Mol Imaging 2017;2017:9512370 doi:10.1155/2017/9512370 pmid:29114182

    CrossRefPubMed
13. 13.↵
    1. Fountain DM,
    2. Soon WC,
    3. Matys T, et al

    . Volumetric growth rates of meningioma and its correlation with histological diagnosis and clinical outcome: a systematic review. Acta Neurochir (Wien) 2017;159:435–45 doi:10.1007/s00701-016-3071-2 pmid:28101641

    CrossRefPubMed
14. 14.↵
    1. Chang V,
    2. Narang J,
    3. Schultz L, et al

    . Computer-aided volumetric analysis as a sensitive tool for the management of incidental meningiomas. Acta Neurochir 2012;154:589–97 doi:10.1007/s00701-012-1273-9 pmid:22302235

    CrossRefPubMed
15. 15.↵
    1. Suh JH

    . Stereotactic radiosurgery for the management of brain metastases. N Engl J Med 2010;362:1119–27 doi:10.1056/NEJMct0806951 pmid:20335588

    CrossRefPubMed
16. 16.↵
    1. Liu Y,
    2. Stojadinovic S,
    3. Hrycushko B, et al

    . A deep convolutional neural network-based automatic delineation strategy for multiple brain metastases stereotactic radiosurgery. PLoS One 2017;12:e0185844 doi:10.1371/journal.pone.0185844 pmid:28985229

    CrossRefPubMed
17. 17.↵
    1. Charron O,
    2. Lallement A,
    3. Jarnet D, et al

    . Automatic detection and segmentation of brain metastases on multimodal MR images with a deep convolutional neural network. Comput Biol Med 2018;95:43–54 doi:10.1016/j.compbiomed.2018.02.004 pmid:29455079

    CrossRefPubMed
18. 18.↵
    1. Bauknecht HC,
    2. Romano VC,
    3. Rogalla P, et al

    . Intra-and interobserver variability of linear and volumetric measurements of brain metastases using contrast-enhanced magnetic resonance imaging. Invest Radiolol 2010;45:49–56 doi:10.1097/RLI.0b013e3181c02ed5 pmid:19996757

    CrossRefPubMed
19. 19.↵
    1. Zhou Z,
    2. Sanders JW,
    3. Johnson JM, et al

    . Computer-aided detection of brain metastases in T1-weighted MRI for stereotactic radiosurgery using deep learning single-shot detectors. Radiology 2020;295:407–15 doi:10.1148/radiol.2020191479 pmid:32181729

    CrossRefPubMed
20. 20.↵
    1. Larson DB,
    2. Chen MC,
    3. Lungren MP, et al

    . Performance of a deep-learning neural network model in assessing skeletal maturity on pediatric hand radiographs. Radiology 2018;287:313–22 doi:10.1148/radiol.2017170236 pmid:29095675

    CrossRefPubMed
21. 21.↵
    1. Lakhani P,
    2. Sundaram B

    . Deep learning at chest radiography: automated classification of pulmonary tuberculosis by using convolutional neural networks. Radiology 2017;284:574–82 doi:10.1148/radiol.2017162326 pmid:28436741

    CrossRefPubMed
22. 22.
    1. Park A,
    2. Chute C,
    3. Rajpurkar P, et al

    . Deep learning-assisted diagnosis of cerebral aneurysms using the HeadXNet model. JAMA Netw open 2019;2:e195600 doi:10.1001/jamanetworkopen.2019.5600 pmid:31173130

    CrossRefPubMed
23. 23.↵
    1. Laukamp KR,
    2. Thiele F,
    3. Shakirin G, et al

    . Fully automated detection and segmentation of meningiomas using deep learning on routine multiparametric MRI. Eur Radiol 2019;29:124–32 doi:10.1007/s00330-018-5595-8 pmid:29943184

    CrossRefPubMed
24. 24.↵
    1. Perkuhn M,
    2. Stavrinou P,
    3. Thiele F, et al

    . Clinical evaluation of a multiparametric deep learning model for glioblastoma segmentation using heterogeneous magnetic resonance imaging data from clinical routine. Invest Radiol 2018;53:647–54 doi:10.1097/RLI.0000000000000484 pmid:29863600

    CrossRefPubMed
25. 25.↵
    1. Kickingereder P,
    2. Isensee F,
    3. Tursunova I, et al

    . Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study. Lancet Oncol 2019;20:728–40 doi:10.1016/S1470-2045(19)30098-1 pmid:30952559

    CrossRefPubMed
26. 26.↵
    1. Kooi T,
    2. Litjens G,
    3. van Ginneken B, et al

    . Large-scale deep learning for computer aided detection of mammographic lesions. Med Image Anal 2017;35:303–12 doi:10.1016/j.media.2016.07.007 pmid:27497072

    CrossRefPubMed
27. 27.
    1. LeCun Y,
    2. Bengio Y,
    3. Hinton G

    . Deep learning. Nature 2015;521:436–44 doi:10.1038/nature14539 pmid:26017442

    CrossRefPubMed
28. 28.↵
    1. Akkus Z,
    2. Galimzianova A,
    3. Hoogi A, et al

    . Deep learning for brain MRI segmentation: state of the art and future directions. J Digit Imaging 2017;30:449–59 doi:10.1007/s10278-017-9983-4 pmid:28577131

    CrossRefPubMed
29. 29.↵
    1. Mazzara GP,
    2. Velthuizen RP,
    3. Pearlman JL, et al

    . Brain tumor target volume determination for radiation treatment planning through automated MRI segmentation. Int J Radiat Oncol Biol Phys 2004;59:300–12 doi:10.1016/j.ijrobp.2004.01.026 pmid:15093927

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Grøvik E,
    2. Yi D,
    3. Iv M, et al

    . Deep learning enables automatic detection and segmentation of brain metastases on multisequence MRI. J Magn Reson Imaging 2020;51:175–82 doi:10.1002/jmri.26766 pmid:31050074

    CrossRefPubMed
31. 31.↵
    1. Noguchi T,
    2. Uchiyama F,
    3. Kawata Y, et al

    . A fundamental study assessing the diagnostic performance of deep learning for a brain metastasis detection task. Magn Reson Med Sci 2020;19:184–94 doi:10.2463/mrms.mp.2019-0063 pmid:31353336

    CrossRefPubMed
32. 32.↵
    1. Bousabarah K,
    2. Ruge M,
    3. Brand JS, et al

    . Deep convolutional neural networks for automated segmentation of brain metastases trained on clinical data. Radiat Oncol 2020;15:87 doi:10.1186/s13014-020-01514-6 pmid:32312276

    CrossRefPubMed
33. 33.↵
    1. Laukamp KR,
    2. Pennig L,
    3. Thiele F, et al

    . Automated meningioma segmentation in multiparametric MRI: comparable effectiveness of a deep learning model and manual segmentation. Clin Neuroradiol 2020 Feb 14. [Epub ahead of print] doi:10.1007/s00062-020-00884-4 pmid:32060575

    CrossRefPubMed
34. 34.↵
    1. Kamnitsas K,
    2. Ledig C,
    3. Newcombe VFJ, et al

    . Efficient multi-scale 3D CNN with fully connected CRF for accurate brain lesion segmentation. Med Image Anal 2017;36:61–78 doi:10.1016/j.media.2016.10.004 pmid:27865153

    CrossRefPubMed
35. 35.↵
    1. Crum WR,
    2. Camara O,
    3. Hill DL

    . Generalized overlap measures for evaluation and validation in medical image analysis. IEEE Trans Med Imaging 2006;25:1451–61 doi:10.1109/TMI.2006.880587 pmid:17117774

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Schoenmaekers J,
    2. Hofman P,
    3. Bootsma G, et al

    . Screening for brain metastases in patients with stage III non–small-cell lung cancer, magnetic resonance imaging or computed tomography? A prospective study. Eur J Cancer 2019;115:88–96 doi:10.1016/j.ejca.2019.04.017 pmid:31129385

    CrossRefPubMed
37. 37.↵
    1. Narita Y,
    2. Shibui S

    . Strategy of surgery and radiation therapy for brain metastases. Int J Clin Oncol 2009;14:275–80 doi:10.1007/s10147-009-0917-0 pmid:19705236

    CrossRefPubMed
38. 38.↵
    1. Bruno MA,
    2. Walker EA,
    3. Abujudeh HH

    . Understanding and confronting our mistakes: the epidemiology of error in radiology and strategies for error reduction. Radiographics 2015;35:1668–76 doi:10.1148/rg.2015150023 pmid:26466178

    CrossRefPubMed
39. 39.↵
    1. Henson JW,
    2. Ulmer S,
    3. Harris GJ

    . Brain tumor imaging in clinical trials. AJNR Am J Neuroradiol 2008;29:419–24 doi:10.3174/ajnr.A0963 pmid:18272557

    Abstract/FREE Full Text
40. 40.↵
    1. Lin NU,
    2. Lee EQ,
    3. Aoyama H, et al

    ; Response Assessment in Neuro-Oncology (RANO) group, Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol 2015;16:e270–78 doi:10.1016/S1470-2045(15)70057-4 pmid:26065612

    CrossRefPubMed
41. 41.↵
    1. Laukamp KR,
    2. Lindemann F,
    3. Weckesser M, et al

    . Multimodal imaging of patients with gliomas confirms ¹¹ C-MET PET as a complementary marker to MRI for noninvasive tumor grading and intraindividual follow-up after therapy. Mol Imaging 2017;16 doi:10.1177/1536012116687651 pmid:28654379

    CrossRefPubMed
42. 42.↵
    1. Menze BH,
    2. Jakab A,
    3. Bauer S, et al

    . The multimodal Brain Tumor Image Segmentation Benchmark (BRATS). IEEE Trans Med Imaging 2015;34:1993–2024 doi:10.1109/TMI.2014.2377694 pmid:25494501

    CrossRefPubMed
43. 43.↵
    1. Laukamp KR,
    2. Pennig L,
    3. Thiele F, et al

    . Automated meningioma segmentation in multiparametric MRI. Clin Neuroradiol 2020 Feb 4. [Epub ahead of print] doi:10.1007/s00062-020-00884-4 pmid:32060575

    CrossRefPubMed
44. 44.↵
    1. Pennig L,
    2. Hoyer UC,
    3. Goertz L, et al

    . Primary central nervous system lymphoma: clinical evaluation of automated segmentation on multiparametric MRI using deep learning. J Magn Reson Imaging 2021;53:259–68 doi:10.1002/jmri.27288 pmid:32662130

    CrossRefPubMed